Completed PHASE3 INTERVENTIONAL 2-arm NCT00449696

Gel-200 Versus Placebo in Osteoarthritis of the Knee

A Multi-Center, Randomized, Double-Blind, Controlled, Parallel-Group Study of a Single Intra-Articular Injection of Gel-200 With a Single Intra-Articular Injection of Phosphate Buffered Saline (PBS) in Osteoarthritis of the Knee.

Sponsor: Seikagaku Corporation

Conditions Osteoarthritis of the Knee

Interventions Gel-200 Placebo

Updated 6 times since 2017 Last updated: Oct 3, 2011 Started: Sep 30, 2006 Primary completion: Dec 31, 2007 Completion: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00449696, this PHASE3 trial focuses on Osteoarthritis of the Knee and remains completed. Sponsored by Seikagaku Corporation, it has been updated 6 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Sep 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Seikagaku Corporation

Data source: Seikagaku Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Plantation, United States